Rapport Therapeutics, Inc. (RAPP)
26.07
+1.63
(+6.67%)
USD |
NASDAQ |
Nov 09, 16:00
26.03
-0.04
(-0.15%)
After-Hours: 20:00
Rapport Therapeutics Total Assets (Quarterly) : 418.56M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 418.56M |
| June 30, 2026 | 458.98M |
| March 31, 2026 | 497.60M |
| December 31, 2025 | 512.43M |
| September 30, 2025 | 535.32M |
| June 30, 2025 | 285.50M |
| Date | Value |
|---|---|
| March 31, 2025 | 302.05M |
| December 31, 2024 | 314.93M |
| September 30, 2024 | 331.14M |
| June 30, 2024 | 346.10M |
| March 31, 2024 | 206.29M |
| December 31, 2023 | 155.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 197.42B |
| ANI Pharmaceuticals, Inc. | 1.568B |
| Corcept Therapeutics, Inc. | 1.034B |
| Veru, Inc. | 37.03M |
| Eli Lilly & Co. | 148.07B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.37M |
| Shareholders Equity (Quarterly) | 391.19M |
| Debt to Equity Ratio | 0.024 |
| Current Ratio | 20.07 |
| Net Debt Paydown Yield | 0.03% |